Freeman Health System, MO, Series 1999B&C Bond Rating Raised To 'AAA/A-1+' Oct 11

  • ID: 1930075
  • October 2011
  • Standard & Poors
1 of 3

DALLAS (Standard & Poor's) Oct. 5, 2011--Standard & Poor's Ratings Services has raised its rating to 'AAA/A-1+' from 'AA+/A-1' on the Missouri Health and Educational Facilities Authority's variable-rate series 1999B and 1999C bonds issued on behalf of Freeman Health System. The rating action is based on the substitution of a letter of credit (LOC) provided by U.S. Bank N.A. (AA-/A-1+). "The 'AAA' long-term component of the rating reflects our opinion of the likelihood that debt service will be paid over the life of the issue," said Standard & Poor's credit analyst Kevin Holloran. "The short-term component of the rating is based solely on the LOC provider," Mr. Holloran added. The 'AAA' long-term component is also based on the application of...

Companies mentioned in this report are: Freeman Hlth Sys,Missouri Hlth & Educl Facs Auth
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Freeman Hlth Sys,Missouri Hlth & Educl Facs Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.